December 23, 2025
The GLP-1 receptor agonist market size is calculated at $62.86 bn in 2025 is to hit $268.37 bn by 2034. GLP-1 receptor agonists are peptide drugs that mimic the GLP-1 hormone to lower blood glucose and aid weight loss. With rising diabetes and obesit...
October 22, 2025
The rising prevalence of Type 2 diabetes has driven the growth of the market in the near future. North America led the global market owing to its advanced healthcare infrastructure in the region....
December 24, 2025
According to market projections, the GLP-1 drugs sector is expected to grow from USD 48.3 billion in 2024 to USD 121.13 billion by 2034, reflecting a CAGR of 9.63%. The GLP-1 drugs market is expanding due to increasing incidences of type 2 diabetes a...
December 26, 2025
According to market projections, the diabetes drugs sector is expected to grow from USD 75.16 billion in 2025 to USD 143.76 billion by 2035, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabet...
November 01, 2025
According to forecasts, the global peptide receptor radionuclide therapy market will grow from USD 2.34 billion in 2024 to USD 6.1 billion by 2034, with an expected CAGR of 10.06%. In 2024, North America led the global peptide receptor radionuclide t...
November 01, 2025
According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific show...
November 01, 2025
According to market estimations, the global thrombopoietin receptor agonists industry, valued at US$ 1.85 billion in 2023, is set to reach US$ 3.74 billion by 2034, driven by rising platelet-related disorders like ITP and AML. Key trends include FD...
November 01, 2025
G-protein-coupled receptors (GPCRs) are critical targets in treating various diseases, including cardiovascular conditions. Recent investments, such as Superluminal's $120 million Series A funding and St. Jude's research collaboration, highlight the ...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com